0.7310
-0.0160
(-2.14%)
At close: February 13 at 8:11:34 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-181,240.0000
-249,583.0000
-299,919.0000
-265,171.0000
-119,935.0000
Investing Cash Flow
163,797.0000
-144,455.0000
74,000.0000
-7,000.0000
4,000.0000
Financing Cash Flow
5.0000
470,855.0000
187,040.0000
318,183.0000
176,967.0000
End Cash Position
333,647.0000
333,620.0000
256,803.0000
294,199.0000
248,618.0000
Capital Expenditure
--
--
-3,000.0000
--
-3,000.0000
Issuance of Capital Stock
5.0000
500,406.0000
200,000.0000
336,000.0000
187,550.0000
Free Cash Flow
-181,240.0000
-249,583.0000
-302,919.0000
-265,171.0000
-122,935.0000
12/31/2020 - 7/22/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HQ1.MU Oruka Therapeutics Inc. R
11.20
+3.70%
8F8.SG SynAct Pharma AB
1.3460
-1.68%
ICY.SG Incyte Corp
66.72
+1.15%
REGN.MX Regeneron Pharmaceuticals, Inc.
13,757.24
+0.80%
605116.SS Aurisco Pharmaceutical Co.,Ltd.
19.75
-2.08%
22UA.DU BioNTech SE
112.70
+4.35%
PH4.F CStone Pharmaceuticals
0.3060
-2.55%
0WA2.IL Cellectis S.A.
1.5200
0.00%
ALGEN.PA genOway Société anonyme
3.5400
+2.31%
REGN34.SA Regeneron Pharmaceuticals, Inc.
64.72
-4.82%